What are the Implications of the Approval of Aduhelm (Aducanumab) to the US Healthcare System?
A conversation with Professor Nicholas Bagley, JD.
Get CAPRA news in your inbox
Subscribe now to stay informed with the latest news and insights from CAPRA!